Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.

Saved in:
Bibliographic Details
Title: Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
Authors: Rödel F; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Fleischmann M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Dapper H; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany., Hoffmann A; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Rödel C; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Martin D; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany., Fokas E; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. emmanouil.fokas@uk-koeln.de.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Jul; Vol. 22 (7), pp. 483-498. Date of Electronic Publication: 2025 May 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40360682
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rödel+F%22">Rödel F</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Fleischmann+M%22">Fleischmann M</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Diefenhardt+M%22">Diefenhardt M</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Dapper+H%22">Dapper H</searchLink>; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+A%22">Hoffmann A</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Rödel+C%22">Rödel C</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Martin+D%22">Martin D</searchLink>; Department of Radiotherapy and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Fokas+E%22">Fokas E</searchLink>; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany. emmanouil.fokas@uk-koeln.de.; Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany. emmanouil.fokas@uk-koeln.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101500077%22">Nature reviews. Clinical oncology</searchLink> [Nat Rev Clin Oncol] 2025 Jul; Vol. 22 (7), pp. 483-498. <i>Date of Electronic Publication: </i>2025 May 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101500077 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1759-4782 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217594774%22">17594774 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40360682
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41571-025-01025-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 483
    Titles:
      – TitleFull: Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rödel F
      – PersonEntity:
          Name:
            NameFull: Fleischmann M
      – PersonEntity:
          Name:
            NameFull: Diefenhardt M
      – PersonEntity:
          Name:
            NameFull: Dapper H
      – PersonEntity:
          Name:
            NameFull: Hoffmann A
      – PersonEntity:
          Name:
            NameFull: Rödel C
      – PersonEntity:
          Name:
            NameFull: Martin D
      – PersonEntity:
          Name:
            NameFull: Fokas E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1759-4782
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nature reviews. Clinical oncology
              Type: main
ResultId 1